Biblio

33557 resultats trouvés
V
Courteau A., Walker P.M, Guillemin M., Oudot A., Garipov R., Cochet A., Brunotte F., Vrigneaud J.M.  2018.  Validation of SiPM-based PET imaging for left ventricular volumes measurements in preclinical imaging: comparison with simultaneously-acquired cardiac magnetic resonance at 7T.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 45:S168-S169.
Courteau A., Walker P.M, Guillemin M., Oudot A., Garipov R., Cochet A., Brunotte F., Vrigneaud J.M.  2018.  Validation of SiPM-based PET imaging for left ventricular volumes measurements in preclinical imaging: comparison with simultaneously-acquired cardiac magnetic resonance at 7T.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 45:S168-S169.
Courteau A., Walker P.M, Guillemin M., Oudot A., Garipov R., Cochet A., Brunotte F., Vrigneaud J.M.  2018.  Validation of SiPM-based PET imaging for left ventricular volumes measurements in preclinical imaging: comparison with simultaneously-acquired cardiac magnetic resonance at 7T.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 45:S168-S169.
Pernod G, Wu H, De Maistre E, Lazarchick J, Kassise J, Aguilar C, Vera PM, Palareti G, D'Angelo A, Grp DETStudy.  2017.  Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study. BLOOD COAGULATION & FIBRINOLYSIS. 28:254-260.
Ysebaert L, Ferrant E, Quinquenel A, Teste A, Clavert A, Brion A, Kamel L, Brigitte P, Guieze R, Michallet A-S.  2020.  Validation of the BALL score to predict OS in R/R CLL patients treated with ibrutinib: a retrospective study from the FILO group. LEUKEMIA & LYMPHOMA. 61:246-247.
Ysebaert L, Ferrant E, Quinquenel A, Teste A, Clavert A, Brion A, Kamel L, Brigitte P, Guieze R, Michallet A-S.  2020.  Validation of the BALL score to predict OS in R/R CLL patients treated with ibrutinib: a retrospective study from the FILO group. LEUKEMIA & LYMPHOMA. 61:246-247.
Mariet A-S, Anota A, Guizard A-V, Grosclaude P, Velten M, Mercier M.  2014.  Validation of the French Version of Expanded Prostate Cancer Index Composite (EPIC) for assessment of health-related quality of life, according to item response theory and classical analyses. QUALITY OF LIFE RESEARCH. 23:166-167.
Mariet A-S, Anota A, Guizard A-V, Grosclaude P, Velten M, Mercier M.  2014.  Validation of the French Version of Expanded Prostate Cancer Index Composite (EPIC) for assessment of health-related quality of life, according to item response theory and classical analyses. QUALITY OF LIFE RESEARCH. 23:166-167.
Devilliers H, Jolly M, Samson M, Bonnotte B, Maurier F, Seve P, Magy-Bertrand N, Wahl D, Pennaforte J-L, Martin T et al..  2016.  Validation of the French Version of Lupus Patient Reported Outcome (LupusPRO), a Disease-Specific Patient Reported Outcome for Lupus Patients. ARTHRITIS & RHEUMATOLOGY. 68
Devilliers H, Jolly M, Samson M, Bonnotte B, Maurier F, Seve P, Magy-Bertrand N, Wahl D, Pennaforte J-L, Martin T et al..  2016.  Validation of the French Version of Lupus Patient Reported Outcome (LupusPRO), a Disease-Specific Patient Reported Outcome for Lupus Patients. ARTHRITIS & RHEUMATOLOGY. 68
Courtois R., Petot J-M, Plaisant O., Allibe B., Lignier B., Reveillere C., Lecocq G., John O..  2020.  Validation of the French version of the 10-item Big Five Inventory. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE. 46:455-462.
Legris N., Daumas A., Devilliers H., Daubail B., Lucas B., Giroud M., Bejot Y..  2016.  Validation of the French version of the Stroke Specific Quality of Life scale (SS-QOL). EUROPEAN JOURNAL OF NEUROLOGY. 23:362.
Legris N., Daumas A., Devilliers H., Daubail B., Lucas B., Giroud M., Bejot Y..  2016.  Validation of the French version of the Stroke Specific Quality of Life scale (SS-QOL). EUROPEAN JOURNAL OF NEUROLOGY. 23:362.
Potard C, Kubiszewski V, Gimenes G, Courtois R.  2014.  Validation of the French version of the Suicidal Ideation Questionnaire among adolescents. PSYCHIATRY RESEARCH. 215:471-476.
Mellerio H, Jacquin P, Trelles N, Le Roux E, Belanger R, Alberti C, Tubiana-Rufi N, Stheneur C, Guilmin-Crepon S, Devilliers H.  2020.  Validation of the ``Good2Go'': the first French-language transition readiness questionnaire. EUROPEAN JOURNAL OF PEDIATRICS. 179:61-71.
Pages F, Andre T, Taieb J, Vernerey D, Henriques J, Borg C, Marliot F, Ben Jannet R, Louvet C, Mineur L et al..  2019.  Validation of the Immunoscore prognostic value in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France cohort study (PRODIGE-GERCOR).. JOURNAL OF CLINICAL ONCOLOGY. 37
Vanwalleghem S, Miljkovitch R, Counsell A, Atkinson L, Vinter A.  2020.  Validation of the Intention Attribution Test for Children (IAC). ASSESSMENT. 27:1619-1632.
Lavaud P, Dalban C, Negrier S, Chevreau C, Gravis G, Oudard S, Laguerre B, Barthelemy P, Borchiellini D, Goupil MGross et al..  2020.  Validation of the lung immune prognostic index (LIPI) in patients with metastatic renal cell carcinoma treated with nivolumab in the GETUG-AFU 26 NIVOREN trial. JOURNAL OF CLINICAL ONCOLOGY. 38
Mouly A.  2015.  Validation of the name Cyclophyllum memaoyaense, a rare species in New Caledonia. ACTA BOTANICA GALLICA. 162:287-288.
Julia E, Fowler NH, Bachy E, Feugier P, Bouabdallah R, Tilly H, M. Palomba L, Fruchart C, , Casasnovas R-O et al..  2019.  Validation of the PRIMA-Prognostic Index for Patients Treated with Rituximab Plus Chemotherapy and Refinement of Prognostic Parameters for Patients on Rituximab Plus Lenalidomide in the Phase III Relevance Trial. BLOOD. 134
Emile J-F, Le Malicot K, Tabernero J, Mini E, Folprecht G, Van Laethem J-L, Julie C, Allard MAntoine, Bennouna J, Lepage C et al..  2016.  Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX plus /- cetuximab: A PETACC8 translational study.. JOURNAL OF CLINICAL ONCOLOGY. 34
Aguilar C, Sartori M, D'Angelo A, Kabrhel C, Groce J, De Maistre E, Wasan SM, Kassis J, Lazarchick J, Kaide C et al..  2018.  Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study. BLOOD COAGULATION & FIBRINOLYSIS. 29:562-566.
Wang Y, Joannic D, Juillion P, Monnet A, Delassus P, Lalande A, Fontaine J-F.  2018.  Validation of the Strain Assessment of a Phantom of Abdominal Aortic Aneurysm: Comparison of Results Obtained From Magnetic Resonance Imaging and Stereovision Measurements. JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME. 140:031001.
Bretillon L, Merle BMJ, Martine L, Gregoire S, Ajana S, Berdeaux O, Bron AM, Creuzot-Garcher C, Korobelnik J-F, Acar N et al..  2019.  Validation of the use of a circulating biomarker of retinal omega-3 polyunsaturated fatty acids in supplementation conditions: the BLISAR project. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 60
Bretillon L, Merle BMJ, Martine L, Gregoire S, Ajana S, Berdeaux O, Bron AM, Creuzot-Garcher C, Korobelnik J-F, Acar N et al..  2019.  Validation of the use of a circulating biomarker of retinal omega-3 polyunsaturated fatty acids in supplementation conditions: the BLISAR project. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 60

Pages